Cargando...

Application of Population Pharmacokinetic Modeling for Individualized Infliximab Dosing Strategies in Crohn's Disease

OBJECTIVES: The pharmacokinetics of infliximab are highly variable in children with Crohn's disease (CD), and a one-size-fits-all approach to dosing is inadequate. Model-based drug dosing can help individualize dosing strategies. We evaluated the predictive performance and clinical utility of a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Pediatr Gastroenterol Nutr
Autores principales: Frymoyer, Adam, Hoekman, Daniël R., Piester, Travis L., de Meij, Tim G., Hummel, Thalia Z., Benninga, Marc A., Kindermann, Angelika, Park, KT
Formato: Artigo
Lenguaje:Inglês
Publicado: 2017
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5670026/
https://ncbi.nlm.nih.gov/pubmed/28471911
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPG.0000000000001620
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!